According to data provided by Zacks Research, The Coca-Cola Co (NYSE:KO) has a consensus target price of $47.25 on the stock. Out of the polled analysts providing targets, the high is currently $51, while the low is resting at $42. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting The Coca-Cola Co (NYSE:KO) to post a current quarter EPS of $0.49. This consensus number is compiled by Zacks Research. For the period ending on 2017-06-30, the company reported EPS for the quarter of $0.59. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was 3.51%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-10-25.
In terms of analyst ratings, The Coca-Cola Co (NYSE:KO) has a current ABR of 2.6. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.
In the most recent session, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) shares have traded +0.36%. Following the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent review, the stock has been noted $-0.46 away from the 50-day moving average of $14.30 and $0.66 away from the 200-day moving average of $13.18. From a different angle, the stock has been recently recorded -50.29% off of the 52-week high of 27.84 and +66.55% removed from the 52-week low of 8.31.
Currently, Valeant Pharmaceuticals Interna has a price to earnings ratio of N/A. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio below one, it may be viewed as undervalued. If a company has a PEG Ratio above one, it may show that the company is overvalued. A PEG Ratio near one may be viewed as fair value. The stock currently has a PEG Ratio of -0.40.
Price Target Update
Analysts polled by Thomson Reuters have set a consensus target price of $16.71 on shares. Target prices may vary from one analyst to another due to the various ways they may proceed to calculate future price targets. This is a near-term estimation for the next 12-18 months.